Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM).
Hofer S, Keller K, Imbach L, Roelcke U, Hutter G, Hundsberger T, Hertler C, Le Rhun E, Vasella F, Cordier D, Neidert M, Hottinger A, Migliorini D, Pflugshaupt T, Eggenberger N, Baumert B, Läubli H, Gramatzki D, Reinert M, Pesce G, Schucht P, Frank I, Lehnick D, Weiss T, Wirsching HG, Wolpert F, Roth P, Weller M. Hofer S, et al. Among authors: roelcke u. Swiss Med Wkly. 2021 May 16;151:w20501. doi: 10.4414/smw.2021.20501. eCollection 2021 May 10. Swiss Med Wkly. 2021. PMID: 34000060 Free article.
MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial.
Wirsching HG, Roelcke U, Weller J, Hundsberger T, Hottinger AF, von Moos R, Caparrotti F, Conen K, Remonda L, Roth P, Ochsenbein A, Tabatabai G, Weller M. Wirsching HG, et al. Among authors: roelcke u. Clin Cancer Res. 2021 Jan 1;27(1):179-188. doi: 10.1158/1078-0432.CCR-20-2096. Epub 2020 Sep 23. Clin Cancer Res. 2021. PMID: 32967939 Free article. Clinical Trial.
Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.
Hundsberger T, Hottinger AF, Roelcke U, Roth P, Migliorini D, Dietrich PY, Conen K, Pesce G, Hermann E, Pica A, Gross MW, Brügge D, Plasswilm L, Weller M, Putora PM. Hundsberger T, et al. Among authors: roelcke u. J Neurooncol. 2016 Jan;126(1):175-183. doi: 10.1007/s11060-015-1957-0. Epub 2015 Oct 12. J Neurooncol. 2016. PMID: 26459327 Free article.
Complementary and alternative medicine use by glioma patients in Switzerland.
Eisele G, Roelcke U, Conen K, Huber F, Weiss T, Hofer S, Heese O, Westphal M, Hertler C, Roth P, Weller M. Eisele G, et al. Among authors: roelcke u. Neurooncol Pract. 2019 May;6(3):237-244. doi: 10.1093/nop/npy035. Epub 2018 Oct 12. Neurooncol Pract. 2019. PMID: 31386047 Free PMC article.
[Neurological complications in cancer patients].
Hundsberger T, Roth P, Roelcke U. Hundsberger T, et al. Among authors: roelcke u. Praxis (Bern 1994). 2014 Aug 20;103(17):1009-16. doi: 10.1024/1661-8157/a001756. Praxis (Bern 1994). 2014. PMID: 25146945 Free article. Review. German.
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.
Wirsching HG, Tabatabai G, Roelcke U, Hottinger AF, Jörger F, Schmid A, Plasswilm L, Schrimpf D, Mancao C, Capper D, Conen K, Hundsberger T, Caparrotti F, von Moos R, Riklin C, Felsberg J, Roth P, Jones DTW, Pfister S, Rushing EJ, Abrey L, Reifenberger G, Held L, von Deimling A, Ochsenbein A, Weller M. Wirsching HG, et al. Among authors: roelcke u. Ann Oncol. 2018 Jun 1;29(6):1423-1430. doi: 10.1093/annonc/mdy120. Ann Oncol. 2018. PMID: 29648580 Free article. Clinical Trial.
78 results